KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 54 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $1,123,000 | +7.2% | 30,000 | 0.0% | 0.12% | -15.8% |
Q3 2014 | $1,048,000 | -25.0% | 30,000 | 0.0% | 0.15% | -23.2% |
Q2 2014 | $1,397,000 | -33.3% | 30,000 | -55.8% | 0.19% | -41.5% |
Q1 2014 | $2,094,000 | +208.8% | 67,800 | +129.1% | 0.32% | +55.5% |
Q4 2013 | $678,000 | – | 29,600 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |